Blood Coagulation Disorders  >>  Thymoglobulin (anti-thymocyte globulin (rabbit))  >>  Phase 1
Welcome,         Profile    Billing    Logout  

2 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Thymoglobulin (anti-thymocyte globulin (rabbit)) / Sanofi
NCT00545519: A Phase I Study Of Thymoglobulin In Patients With Relapsed Or Refractory Multiple Myeloma

Completed
1
6
US
thymoglobulin, Vidaza
Washington University School of Medicine, Genzyme, a Sanofi Company
Relapsed Or Refractory Multiple Myeloma
03/08
03/08
NCT00317798: Antithymocyte Globulin and Sirolimus in Treating Patients With Relapsed Multiple Myeloma

Completed
1
18
US
anti-thymocyte globulin, sirolimus
University of Rochester
Drug/Agent Toxicity by Tissue/Organ, Multiple Myeloma and Plasma Cell Neoplasm
04/11
04/11

Download Options